(CKI) Clarke - Ratings and Ratios
Exchange: TO • Country: Canada • Currency: CAD • Type: Common Stock • ISIN: CA1819013071
CKI: Energy, Materials, Real Estate, Manufacturing, Industrial
Clarke Inc. (TO: CKI) is a private equity and venture capital firm focused on middle-market investments, specializing in turnaround situations, PIPEs (public investments in private equity), bridge financing, recapitalization, and buyouts. The firm targets undervalued or underperforming businesses with tangible hard assets, investing in both public and private entities across various sectors, including manufacturing, industrial, energy, materials, and real estate. Clarke Inc. prioritizes investments in equity and debt securities, with a preference for well-priced equity over debt, particularly in oilfield services companies rather than exploration and production (E&P) firms. The firm actively engages in active involvement in portfolio company governance, often participating in board-level decision-making. Clarke Inc. primarily operates in Canada and the United States, with a focus on balance sheet-driven investments.
Clarke Inc. (TO: CKI) operates in the Hotels, Resorts & Cruise Lines sub-industry, though its core business revolves around private equity and venture capital investments. The firm was established in 1997 and is headquartered in Halifax, Canada. For more information, visit their official website at https://www.clarkeinc.com.
Three-Month Forecast: Based on current technical and fundamental data, Clarke Inc. (TO: CKI) is expected to experience sideways price action with potential downside risks. The stocks short-term moving averages (SMA 20: 23.02, SMA 50: 23.35) suggest resistance at the 23.00 level, while the long-term SMA 200 (22.63) indicates support near current levels. The Average True Range (ATR: 0.07) reflects low volatility, suggesting limited price movement. Fundamentally, the stock trades at a P/E of 13.23 with a P/B ratio of 1.23, indicating fair valuation. However, the lack of forward P/E data and a P/S ratio of 3.79 may signal cautious investor sentiment. Over the next three months, Clarke Inc. is likely to trade in a narrow range between 22.00 and 23.50, with potential dips below the SMA 200 if broader market conditions deteriorate.
Additional Sources for CKI Stock
CKI Stock Overview
Market Cap in USD | 216m |
Sector | Consumer Cyclical |
Industry | Lodging |
GiC Sub-Industry | Hotels, Resorts & Cruise Lines |
IPO / Inception |
CKI Stock Ratings
Growth 5y | 70.4% |
Fundamental | 36.2% |
Dividend | 8.89% |
Rel. Strength Industry | 3.66 |
Analysts | - |
Fair Price Momentum | 22.32 CAD |
Fair Price DCF | 3.29 CAD |
CKI Dividends
Dividend Yield 12m | 0.00% |
Yield on Cost 5y | % |
Annual Growth 5y | 0.00% |
Payout Consistency | 29.6% |
CKI Growth Ratios
Growth Correlation 3m | -92.8% |
Growth Correlation 12m | 42% |
Growth Correlation 5y | 98.3% |
CAGR 5y | 15.89% |
CAGR/Max DD 5y | 0.28 |
Sharpe Ratio 12m | -0.16 |
Alpha | 7.74 |
Beta | -0.18 |
Volatility | 13.08% |
Current Volume | 2.9k |
Average Volume 20d | 1.6k |
As of March 14, 2025, the stock is trading at CAD 22.19 with a total of 2,900 shares traded.
Over the past week, the price has changed by -0.72%, over one month by -5.37%, over three months by -5.97% and over the past year by +11.23%.
Partly, yes. Based on ValueRay Fundamental Analyses, Clarke (TO:CKI) is currently (March 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 36.16 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CKI as of March 2025 is 22.32. This means that CKI is currently overvalued and has a potential downside of 0.59%.
Clarke has no consensus analysts rating.
According to ValueRays Forecast Model, CKI Clarke will be worth about 24.1 in March 2026. The stock is currently trading at 22.19. This means that the stock has a potential upside of +8.65%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 24.1 | 8.7% |